Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kaleko

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Human Gene Therapy|January 1, 1990
Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectorsW R Osborne, R A Hock, M Kaleko, et al.
Journal of Cellular Physiology|June 1, 1994
Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiationL S Quinn, B Steinmetz, A Maas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac miceJ A Bristol, P Shirley, N Idamakanti, et al.
Oncogene|September 1, 1992
Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptorV R Chazin, M Kaleko, A D Miller, et al.
Blood|April 15, 1990
Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrowM Kaleko, J V Garcia, W R Osborne, et al.
Blood|June 1, 1996
Sustained expression of therapeutic levels of human factor VIII in miceS Connelly, J M Gardner, R M Lyons, et al.
The Journal of Biological Chemistry|November 4, 1994
c phosphorylation and activation of the IGF-I receptor in src-transformed cellsJ E Peterson, T Jelinek, M Kaleko, et al.
Blood Cells, Molecules & Diseases|June 27, 1998
An improved method for generating retroviral producer clones for vectors lacking a selectable marker geneD A Persons, M G Mehaffey, M Kaleko, et al.
Gene Therapy|July 29, 2003
Synthesis of adenoviral targeting molecules by intein-mediated protein ligationO Nyanguile, C Dancik, J Blakemore, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIIIJ L Andrews, M J Kadan, M I Gorziglia, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Human Gene Therapy|January 1, 1990
Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectorsW R Osborne, R A Hock, M Kaleko, et al.
Journal of Cellular Physiology|June 1, 1994
Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiationL S Quinn, B Steinmetz, A Maas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac miceJ A Bristol, P Shirley, N Idamakanti, et al.
Oncogene|September 1, 1992
Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptorV R Chazin, M Kaleko, A D Miller, et al.
Blood|April 15, 1990
Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrowM Kaleko, J V Garcia, W R Osborne, et al.
Blood|June 1, 1996
Sustained expression of therapeutic levels of human factor VIII in miceS Connelly, J M Gardner, R M Lyons, et al.
The Journal of Biological Chemistry|November 4, 1994
c phosphorylation and activation of the IGF-I receptor in src-transformed cellsJ E Peterson, T Jelinek, M Kaleko, et al.
Blood Cells, Molecules & Diseases|June 27, 1998
An improved method for generating retroviral producer clones for vectors lacking a selectable marker geneD A Persons, M G Mehaffey, M Kaleko, et al.
Gene Therapy|July 29, 2003
Synthesis of adenoviral targeting molecules by intein-mediated protein ligationO Nyanguile, C Dancik, J Blakemore, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIIIJ L Andrews, M J Kadan, M I Gorziglia, et al.
Pageof 4